Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Classification of the present pharmaceutical agents based on the possible effective mechanism on the COVID-19 infection

30 Jul 2020

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to COVID-19 Clinical Research Studies
Share to Diverse Scientific Research Studies
Share to SARS-CoV-2 and COVID-19 Research

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 32734518
DOI: 10.1007/s40199-020-00359-4

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Classification of the present pharmaceutical agents based on the possible effective mechanism on the COVID-19 infectionPMID 32734518Read ↗

Molecular Mechanisms of the Medicines for COVID-19Semantic proximity Read ↗

Comparative efficacy and safety of current drugs against COVID-19: A systematic review and network meta-analysisSemantic proximity Read ↗

Global multi-omics and systems pharmacological strategy unravel the multi-targeted therapeutic potential of natural bioactive molecules against COVID-19: An in silico approachSemantic proximity Read ↗

Drug-repurposing against COVID-19 by targeting a key signaling pathway: An in silico studySemantic proximity Read ↗

COVID-19, Infection Inhibitors and MedicinesSemantic proximity Read ↗

Small molecules in the treatment of COVID-19Semantic proximity Read ↗

Computational studies by molecular docking of some antiviral drugs with COVID-19 receptors are an approach to medication for COVID-19Semantic proximity Read ↗

DEVELOPING NEW DUAL-ACTION ANTIVIRAL/ANTI-INFLAMMATORY SMALL MOLECULES FOR COVID-19 TREATMENT USING IN SILICO AND IN-VITRO APPROACHESSemantic proximity Read ↗

Flavonoid as possible therapeutic targets against COVID-19: a scoping review of in silico studiesSemantic proximity Read ↗

In Silico Evaluation of Prospective Anti-COVID-19 Drug Candidates as Potential SARS-CoV-2 Main Protease InhibitorsSemantic proximity Read ↗

Potential Therapeutic Agents and Associated Bioassay Data for COVID-19 and Related Human Coronavirus InfectionsSemantic proximity Read ↗

Research Into Potential Therapies Against COVID-19, With Focus On IvermectinSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.